INHIBRX BIOSCIENCES, INC.: cashflow_investing
| Value | {"amount": -4593000, "concept": "us-gaap:NetCashProvidedByUsedInInvestingActivities", "currency": "USD"} |
|---|---|
| Period | 2023-01-01 – 2023-12-31 |
| Status | current |
| Entity | INHIBRX BIOSCIENCES, INC. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T19:04:56.173212+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/b52a081f-e318-48f4-a152-5b6c1b8a8ec3
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0002007919-25-000019Retrieved: 2026-08-19T19:04:56.173212+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0002007919/cashflow-investing/2023-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/b52a081f-e318-48f4-a152-5b6c1b8a8ec3
History
- no predecessors — first report